Deisseroth, K. Optogenetics. Nat. Methods 8, 26–29 (2011).
Google Scholar
Duarte, M. J. et al. Ancestral adeno-associated virus vector delivery of opsins to spiral ganglion neurons: implications for optogenetic cochlear implants. Mol. Ther. 26, 1931–1939 (2018).
Google Scholar
Wang, S. et al. Non-invasive, focused ultrasound-facilitated gene delivery for optogenetics. Sci. Rep. 7, 39955 (2017).
Google Scholar
Pathak, G. P. et al. Bidirectional approaches for optogenetic regulation of gene expression in mammalian cells using Arabidopsis cryptochrome 2. Nucleic Acids Res. 45, e167/161–e167/112 (2017).
Kim, T.-i et al. Injectable, cellular-scale optoelectronics with applications for wireless optogenetics. Science 340, 211–216 (2013).
Google Scholar
Wykes, R. C. et al. Optogenetic and potassium channel gene therapy in a rodent model of focal neocortical epilepsy. Sci. Transl. Med. 4, 161ra152 (2012).
Google Scholar
Chow, B. Y. & Boyden, E. S. Optogenetics and translational medicine. Sci. Transl. Med. 5, 177ps175 (2013).
Galvan, A. et al. Nonhuman primate optogenetics: recent advances and future directions. J. Neurosci. 37, 10894–10903 (2017).
Google Scholar
Eichler, J., Knof, J. & Lenz, H. Measurements on the depth of penetration of light (0.35–1.0 µm) in tissue. Radiat. Environ. Biophys. 14, 239–242 (1977).
Google Scholar
Lin, X. et al. Core–shell–shell upconversion nanoparticles with enhanced emission for wireless optogenetic inhibition. Nano Lett. 18, 948–956 (2018).
Google Scholar
Mager, T. et al. High frequency neural spiking and auditory signaling by ultrafast red-shifted optogenetics. Nat. Commun. 9, 1750 (2018).
Google Scholar
Nagel, G. et al. Channelrhodopsin-2, a directly light-gated cation-selective membrane channel. Proc. Natl Acad. Sci. USA 100, 13940–13945 (2003).
Google Scholar
Pathak, G. P., Vrana, J. D. & Tucker, C. L. Optogenetic control of cell function using engineered photoreceptors. Biol. Cell 105, 59–72 (2013).
Google Scholar
Reichhart, E., Ingles-Prieto, A., Tichy, A. M., McKenzie, C. & Janovjak, H. A phytochrome sensory domain permits receptor activation by red light. Angew. Chem. Int. Ed. 55, 6339–6342 (2016).
Google Scholar
Zhang, F. et al. The microbial opsin family of optogenetic tools. Cell 147, 1446–1457 (2011).
Google Scholar
Zhang, F., Wang, L.-P., Boyden, E. S. & Deisseroth, K. Channelrhodopsin-2 and optical control of excitable cells. Nat. Methods 3, 785–792 (2006).
Google Scholar
Krook-Magnuson, E., Armstrong, C., Oijala, M. & Soltesz, I. On-demand optogenetic control of spontaneous seizures in temporal lobe epilepsy. Nat. Commun. 4, 1376 (2013).
Google Scholar
Chen, Y., Xiong, M. & Zhang, S.-C. Illuminating Parkinson’s therapy with optogenetics. Nat. Biotechnol. 33, 149–150 (2015).
Google Scholar
Lüscher, C. & Malenka, R. C. Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling. Neuron 69, 650–663 (2011).
Google Scholar
Gradinaru, V., Thompson, K. R. & Deisseroth, K. eNpHR: a Natronomonas halorhodopsin enhanced for optogenetic applications. Brain Cell Biol. 36, 129–139 (2008).
Google Scholar
Han, X. et al. A high-light sensitivity optical neural silencer: development and application to optogenetic control of non-human primate cortex. Front. Syst. Neurosci. 5, 18 (2011).
Google Scholar
Tye, K. M. et al. Amygdala circuitry mediating reversible and bidirectional control of anxiety. Nature 471, 358–362 (2011).
Google Scholar
Tye, K. M. et al. Dopamine neurons modulate neural encoding and expression of depression-related behaviour. Nature 493, 537–541 (2013).
Google Scholar
Wietek, J. et al. Conversion of channelrhodopsin into a light-gated chloride channel. Science 344, 409–412 (2014).
Google Scholar
Berndt, A., Lee, S. Y., Ramakrishnan, C. & Deisseroth, K. Structure-guided transformation of channelrhodopsin into a light-activated chloride channel. Science 344, 420–424 (2014).
Google Scholar
Berndt, A. & Deisseroth, K. Expanding the optogenetics toolkit. Science 349, 590–591 (2015).
Google Scholar
Govorunova, E. G., Sineshchekov, O. A., Janz, R., Liu, X. & Spudich, J. L. Natural light-gated anion channels: a family of microbial rhodopsins for advanced optogenetics. Science 349, 647–650 (2015).
Google Scholar
Arrenberg, A. B., Stainier, D. Y., Baier, H. & Huisken, J. Optogenetic control of cardiac function. Science 330, 971–974 (2010).
Google Scholar
Bruegmann, T. et al. Optogenetic control of heart muscle in vitro and in vivo. Nat. Methods 7, 897–900 (2010).
Google Scholar
Doroudchi, M. M. et al. Virally delivered channelrhodopsin-2 safely and effectively restores visual function in multiple mouse models of blindness. Mol. Ther. 19, 1220–1229 (2011).
Google Scholar
Ye, H., Daoud-El Baba, M., Peng, R.-W. & Fussenegger, M. A synthetic optogenetic transcription device enhances blood-glucose homeostasis in mice. Science 332, 1565–1568 (2011).
Google Scholar
Chen, D., Gibson, E. S. & Kennedy, M. J. A light-triggered protein secretion system. J. Cell Biol. 201, 631–640 (2013).
Google Scholar
Tyszkiewicz, A. B. & Muir, T. W. Activation of protein splicing with light in yeast. Nat. Methods 5, 303–305 (2008).
Google Scholar
Liu, H., Gomez, G., Lin, S., Lin, S. & Lin, C. Optogenetic control of transcription in zebrafish. PLoS ONE 7, e50738 (2012).
Google Scholar
Zhou, X. X., Chung, H. K., Lam, A. J. & Lin, M. Z. Optical control of protein activity by fluorescent protein domains. Science 338, 810–814 (2012).
Google Scholar
Wu, Y. I. et al. A genetically encoded photoactivatable Rac controls the motility of living cells. Nature 461, 104–108 (2009).
Google Scholar
Zhang, K. & Cui, B. Optogenetic control of intracellular signaling pathways. Trends Biotechnol. 33, 92–100 (2015).
Google Scholar
Madisen, L. et al. A toolbox of Cre-dependent optogenetic transgenic mice for light-induced activation and silencing. Nat. Neurosci. 15, 793–802 (2012).
Google Scholar
Zhang, F. et al. Optogenetic interrogation of neural circuits: technology for probing mammalian brain structures. Nat. Protoc. 5, 439–456 (2010).
Google Scholar
Williams, J. C. & Denison, T. From optogenetic technologies to neuromodulation therapies. Sci. Transl. Med. 5, 177ps176 (2013).
Edelstein, M. L., Abedi, M. R. & Wixon, J. Gene therapy clinical trials worldwide to 2007—an update. J. Gene Med. 9, 833–842 (2007).
Google Scholar
Kaplitt, M. G. et al. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson’s disease: an open label, phase I trial. Lancet 369, 2097–2105 (2007).
Google Scholar
Pickar, A. K. & Gersbach, C. A. Gene therapies for hemophilia hit the mark in clinical trials. Nat. Med. 24, 121–122 (2018).
Google Scholar
Mingozzi, F. & High, K. A. Immune responses to AAV vectors: overcoming barriers to successful gene therapy. Blood 122, 23–36 (2013).
Google Scholar
Smalley, E. First AAV gene therapy poised for landmark approval. Nat. Biotechnol. 35, 998–1000 (2017).
Google Scholar
Ambrosi, C. M., Sadananda, G., Klimas, A. & Entcheva, E. Adeno-associated virus mediated gene delivery: Implications for scalable in vitro and in vivo cardiac optogenetic models. Front Physiol. 10, 168 (2019).
Google Scholar
Ginn, S. L., Amaya, A. K., Alexander, I. E., Edelstein, M. & Abedi, M. R. Gene therapy clinical trials worldwide to 2017: an update. J. Gene Med. 20, e3015 (2018).
Google Scholar
Colella, P., Ronzitti, G. & Mingozzi, F. Emerging issues in AAV-mediated in vivo gene therapy. Mol. Ther. Methods Clin. Dev. 8, 87–104 (2018).
Google Scholar
Pastrana, E. Optogenetics: controlling cell function with light. Nat. Methods 8, 24–25 (2010).
Stujenske, J. M., Spellman, T. & Gordon, J. A. Modeling the spatiotemporal dynamics of light and heat propagation for in vivo optogenetics. Cell Rep. 12, 525–534 (2015).
Google Scholar
Yizhar, O., Fenno, L. E., Davidson, T. J., Mogri, M. & Deisseroth, K. Optogenetics in neural systems. Neuron 71, 9–34 (2011).
Google Scholar
Fowley, C., Nomikou, N., McHale, A. P., McCaughan, B. & Callan, J. F. Extending the tissue penetration capability of conventional photosensitisers: a carbon quantum dot–protoporphyrin IX conjugate for use in two-photon excited photodynamic therapy. Chem. Commun. 49, 8934–8936 (2013).
Google Scholar
Brancaleon, L. & Moseley, H. Laser and non-laser light sources for photodynamic therapy. Lasers Med. Sci. 17, 173–186 (2002).
Google Scholar
Aravanis, A. M. et al. An optical neural interface: in vivo control of rodent motor cortex with integrated fiberoptic and optogenetic technology. J. Neural Eng. 4, S143–S156 (2007).
Google Scholar
Wilson, B. & Adam, G. A Monte Carlo model for the absorption and flux distributions of light in tissue. Med. Phys. 10, 824–830 (1983).
Google Scholar
Montgomery, K. L. et al. Wirelessly powered, fully internal optogenetics for brain, spinal and peripheral circuits in mice. Nat. Methods 12, 969–974 (2015).
Google Scholar
Won, S. M., Cai, L., Gutruf, P. & Rogers, J. A. Wireless and battery-free technologies for neuroengineering. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-021-00683-3 (2021).
Krook-Magnuson, E. et al. In vivo evaluation of the dentate gate theory in epilepsy. J. Physiol. 593, 2379–2388 (2015).
Google Scholar
Tønnesen, J., Sørensen, A. T., Deisseroth, K., Lundberg, C. & Kokaia, M. Optogenetic control of epileptiform activity. Proc. Natl Acad. Sci. USA 106, 12162–12167 (2009).
Google Scholar
Soper, C., Wicker, E., Kulick, C. V., N’Gouemo, P. & Forcelli, P. A. Optogenetic activation of superior colliculus neurons suppresses seizures originating in diverse brain networks. Neurobiol. Dis. 87, 102–115 (2016).
Google Scholar
Krook-Magnuson, E., Szabo, G. G., Armstrong, C., Oijala, M. & Soltesz, I. Cerebellar directed optogenetic intervention inhibits spontaneous hippocampal seizures in a mouse model of temporal lobe epilepsy. eNeuro 1, PMC4293636 (2014).
Sidor, M. M. Psychiatry’s age of enlightenment: optogenetics and the discovery of novel targets for the treatment of psychiatric disorders. J. Psychiatry Neurosci. 37, 4–6 (2012).
Google Scholar
Stefanik, M. T. et al. Optogenetic inhibition of cocaine seeking in rats. Addict. Biol. 18, 50–53 (2013).
Google Scholar
Chaudhury, D. et al. Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons. Nature 493, 532–536 (2013).
Google Scholar
Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819–823 (2013).
Google Scholar
Tsai, S. Q. & Joung, J. K. Defining and improving the genome-wide specificities of CRISPR–Cas9 nucleases. Nat. Rev. Genet. 17, 300–312 (2016).
Google Scholar
Nihongaki, Y., Kawano, F., Nakajima, T. & Sato, M. Photoactivatable CRISPR-Cas9 for optogenetic genome editing. Nat. Biotechnol. 33, 755–760 (2015).
Google Scholar
Busskamp, V., Picaud, S., Sahel, J.-A. & Roska, B. Optogenetic therapy for retinitis pigmentosa. Gene Ther. 19, 169–175 (2012).
Google Scholar
Marc, R., Pfeiffer, R. & Jones, B. Retinal prosthetics, optogenetics, and chemical photoswitches. ACS Chem. Neurosci. 5, 895–901 (2014).
Google Scholar
Busskamp, V. et al. Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosa. Science 329, 413–417 (2010).
Google Scholar
Kalloniatis, M., Nivison-Smith, L., Chua, J., Acosta, M. & Fletcher, E. Using the rd1 mouse to understand functional and anatomical retinal remodelling and treatment implications in retinitis pigmentosa: a review. Exp. Eye Res. 150, 106–121 (2016).
Google Scholar
Bi, A. et al. Ectopic expression of a microbial-type rhodopsin restores visual responses in mice with photoreceptor degeneration. Neuron 50, 23–33 (2006).
Google Scholar
Tomita, H. et al. Channelrhodopsin-2 gene transduced into retinal ganglion cells restores functional vision in genetically blind rats. Exp. Eye Res. 90, 429–436 (2010).
Google Scholar
Thyagarajan, S. et al. Visual function in mice with photoreceptor degeneration and transgenic expression of channelrhodopsin 2 in ganglion cells. J. Neurosci. 30, 8745–8758 (2010).
Google Scholar
Tomita, H. et al. Visual properties of transgenic rats harboring the channelrhodopsin-2 gene regulated by the thy-1.2 promoter. PLoS ONE 4, e7679 (2009).
Google Scholar
Fradot, M. et al. Gene therapy in ophthalmology: validation on cultured retinal cells and explants from postmortem human eyes. Hum. Gene Ther. 22, 587–593 (2010).
Sahel, J.-A. et al. Partial recovery of visual function in a blind patient after optogenetic therapy. Nat. Med. 27, 1223–1229 (2021).
Google Scholar
van Wyk, M., Pielecka-Fortuna, J., Löwel, S. & Kleinlogel, S. Restoring the ON switch in blind retinas: opto-mGluR6, a next-generation, cell-tailored optogenetic tool. PLoS Biol. 13, e1002143 (2015).
Google Scholar
Mager, T. et al. High frequency neural spiking and auditory signaling by ultrafast red-shifted optogenetics. Nat. Commun. 9, 1750 (2018).
Google Scholar
Weiss, R. S., Voss, A. & Hemmert, W. Optogenetic stimulation of the cochlea—A review of mechanisms, measurements, and first models. Network 27, 212–236 (2016).
Google Scholar
Furman, A. C., Kujawa, S. G. & Liberman, M. C. Noise-induced cochlear neuropathy is selective for fibers with low spontaneous rates. J. Neurophysiol. 110, 577–586 (2013).
Google Scholar
Jeschke, M. & Moser, T. Considering optogenetic stimulation for cochlear implants. Hear. Res. 322, 224–234 (2015).
Google Scholar
Caracciolo, L. et al. CREB controls cortical circuit plasticity and functional recovery after stroke. Nat. Commun. 9, 2250 (2018).
Google Scholar
Hernandez, V. H. et al. Optogenetic stimulation of the auditory pathway. J. Clin. Invest. 124, 1114–1129 (2014).
Google Scholar
Miller, C. A. et al. Electrical excitation of the acoustically sensitive auditory nerve: single-fiber responses to electric pulse trains. J. Assoc. Res. Otolaryngol. 7, 195–210 (2006).
Google Scholar
Hight, A. E. et al. Superior temporal resolution of Chronos versus channelrhodopsin-2 in an optogenetic model of the auditory brainstem implant. Hear. Res. 322, 235–241 (2015).
Google Scholar
Wrobel, C. et al. Optogenetic stimulation of cochlear neurons activates the auditory pathway and restores auditory-driven behavior in deaf adult gerbils. Sci. Transl. Med. 10, eaao0540 (2018).
Google Scholar
Goßler, C. et al. GaN-based micro-LED arrays on flexible substrates for optical cochlear implants. J. Phys. D Appl. Phys. 47, 205401 (2014).
Iyer, S. M. et al. Virally mediated optogenetic excitation and inhibition of pain in freely moving nontransgenic mice. Nat. Biotechnol. 32, 274–278 (2014).
Google Scholar
May, T. et al. Detection of optogenetic stimulation in somatosensory cortex by non-human primates – towards artificial tactile sensation. PLoS ONE 9, e114529 (2014).
Google Scholar
Stauffer, W. R. et al. Dopamine neuron-specific optogenetic stimulation in rhesus macaques. Cell 166, 1564–1571.e6 (2016).
Google Scholar
Cavanaugh, J. et al. Optogenetic inactivation modifies monkey visuomotor behavior. Neuron 76, 901–907 (2012).
Google Scholar
Kim, H. K., Alexander, A. L. & Soltesz, I. in Optogenetics: A Roadmap (ed. Stroh, A.) 277–300 (Springer, 2018).
Cardin, J. A. et al. Targeted optogenetic stimulation and recording of neurons in vivo using cell-type-specific expression of Channelrhodopsin-2. Nat. Protoc. 5, 247–254 (2010).
Google Scholar
Murlidharan, G., Samulski, R. J. & Asokan, A. Biology of adeno-associated viral vectors in the central nervous system. Front. Mol. Neurosci. 7, 76 (2014).
Google Scholar
Dunbar, C. E. et al. Gene therapy comes of age. Science 359, eaan4672 (2018).
Google Scholar
Kessler, P. D. et al. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc. Natl Acad. Sci. USA 93, 14082–14087 (1996).
Google Scholar
Nussinovitch, U. & Gepstein, L. Optogenetics for in vivo cardiac pacing and resynchronization therapies. Nat. Biotechnol. 33, 750–754 (2015).
Google Scholar
Kravitz, A. V. et al. Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry. Nature 466, 622–626 (2010).
Google Scholar
Metzger, D. & Feil, R. Engineering the mouse genome by site-specific recombination. Curr. Opin. Biotechnol. 10, 470–476 (1999).
Google Scholar
Kohara, K. et al. Cell type-specific genetic and optogenetic tools reveal hippocampal CA2 circuits. Nat. Neurosci. 17, 269–279 (2014).
Google Scholar
Han, S. Y., McLennan, T., Czieselsky, K. & Herbison, A. E. Selective optogenetic activation of arcuate kisspeptin neurons generates pulsatile luteinizing hormone secretion. Proc. Natl Acad. Sci. USA 112, 13109–13114 (2015).
Google Scholar
Li, Y. et al. Optogenetic activation of adenosine A 2A receptor signaling in the dorsomedial striatopallidal neurons suppresses goal-directed behavior. Neuropsychopharmacology 41, 1003–1013 (2016).
Google Scholar
Cronin, T. et al. Efficient transduction and optogenetic stimulation of retinal bipolar cells by a synthetic adeno-associated virus capsid and promoter. EMBO Mol. Med. 6, 1175–1190 (2014).
Google Scholar
Lu, Q. et al. AAV-mediated transduction and targeting of retinal bipolar cells with improved mGluR6 promoters in rodents and primates. Gene Ther. 23, 680–689 (2016).
Google Scholar
Chan, K. Y. et al. Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems. Nat. Neurosci. 20, 1172–1179 (2017).
Google Scholar
Manno, C. S. et al. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat. Med. 12, 342–347 (2006).
Google Scholar
Boutin, S. et al. Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors. Hum. Gene Ther. 21, 704–712 (2010).
Google Scholar
Salganik, M., Hirsch, M. L. & Samulski, R. J. Adeno-associated virus as a mammalian DNA vector. Microbiol. Spectr. 3, 827–849 (2015).
Senova, S. et al. Optogenetic tractography for anatomo-functional characterization of cortico-subcortical neural circuits in non-human primates. Sci. Rep. 8, 3362 (2018).
Google Scholar
Kyung, T. et al. Optogenetic control of endogenous Ca 2+ channels in vivo. Nat. Biotechnol. 33, 1092–1096 (2015).
Google Scholar
Paonessa, F. et al. Regulation of neural gene transcription by optogenetic inhibition of the RE1-silencing transcription factor. Proc. Natl Acad. Sci. USA 113, E91–E100 (2016).
Google Scholar
Danjo, T., Yoshimi, K., Funabiki, K., Yawata, S. & Nakanishi, S. Aversive behavior induced by optogenetic inactivation of ventral tegmental area dopamine neurons is mediated by dopamine D2 receptors in the nucleus accumbens. Proc. Natl. Acad. Sci. USA 111, 6455–6460 (2014).
Google Scholar
Ben-Simon, Y. et al. A combined optogenetic-knockdown strategy reveals a major role of tomosyn in mossy fiber synaptic plasticity. Cell Rep. 12, 396–404 (2015).
Google Scholar
Seeger-Armbruster, S. et al. Patterned, but not tonic, optogenetic stimulation in motor thalamus improves reaching in acute drug-induced parkinsonian rats. J. Neurosci. 35, 1211–1216 (2015).
Google Scholar
Andersson, M. et al. Optogenetic control of human neurons in organotypic brain cultures. Sci. Rep. 6, 24818 (2016).
Google Scholar
Jackman, S. L. et al. Silk fibroin films facilitate single-step targeted expression of optogenetic proteins. Cell Rep. 22, 3351–3361 (2018).
Google Scholar
Galvan, A., Hu, X., Smith, Y. & Wichmann, T. Effects of optogenetic activation of corticothalamic terminals in the motor thalamus of awake monkeys. J. Neurosci. 36, 3519–3530 (2016).
Google Scholar
Naso, M. F., Tomkowicz, B., Perry, W. L. & Strohl, W. R. Adeno-associated virus (AAV) as a vector for gene therapy. BioDrugs 31, 317–334 (2017).
Google Scholar
Nathwani, A. C. et al. Long-term safety and efficacy following systemic administration of a self-complementary AAV vector encoding human FIX pseudotyped with serotype 5 and 8 capsid proteins. Mol. Ther. 19, 876–885 (2011).
Google Scholar
Niemeyer, G. P. et al. Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy. Blood 113, 797–806 (2009).
Google Scholar
Nathwani, A. C. et al. Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N. Engl. J. Med. 365, 2357–2365 (2011).
Google Scholar
Yin, H. et al. Non-viral vectors for gene-based therapy. Nat. Rev. Genet. 15, 541–555 (2014).
Google Scholar
Kesharwani, P. & Iyer, A. K. Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery. Drug Discov. Today 20, 536–547 (2015).
Google Scholar
Lv, H., Zhang, S., Wang, B., Cui, S. & Yan, J. Toxicity of cationic lipids and cationic polymers in gene delivery. J. Control. Release 114, 100–109 (2006).
Google Scholar
Sharei, A. et al. A vector-free microfluidic platform for intracellular delivery. Proc. Natl. Acad. Sci. USA 110, 2082–2087 (2013).
Google Scholar
Mehier-Humbert, S. & Guy, R. H. Physical methods for gene transfer: improving the kinetics of gene delivery into cells. Adv. Drug Deliv. Rev. 57, 733–753 (2005).
Google Scholar
Buerli, T. et al. Efficient transfection of DNA or shRNA vectors into neurons using magnetofection. Nat. Protoc. 2, 3090–3101 (2007).
Google Scholar
Soto-Sánchez, C. et al. Enduring high-efficiency in vivo transfection of neurons with non-viral magnetoparticles in the rat visual cortex for optogenetic applications. Nanomedicine 11, 835–843 (2015).
Google Scholar
Hsieh, F.-Y., Lin, H.-H. & Hsu, S.-h 3D bioprinting of neural stem cell-laden thermoresponsive biodegradable polyurethane hydrogel and potential in central nervous system repair. Biomaterials 71, 48–57 (2015).
Google Scholar
Hsieh, F.-Y. et al. Non-viral delivery of an optogenetic tool into cells with self-healing hydrogel. Biomaterials 174, 31–40 (2018).
Google Scholar
Steinbeck, J. A. et al. Optogenetics enables functional analysis of human embryonic stem cell-derived grafts in a Parkinson’s disease model. Nat. Biotechnol. 33, 204–209 (2015).
Google Scholar
Piña-Crespo, J. C. et al. High-frequency hippocampal oscillations activated by optogenetic stimulation of transplanted human ESC-derived neurons. J. Neurosci. 32, 15837–15842 (2012).
Google Scholar
Weick, J. P. et al. Functional control of transplantable human ESC-derived neurons via optogenetic targeting. Stem Cells 28, 2008–2016 (2010).
Google Scholar
Henderson, K. W. et al. Long-term seizure suppression and optogenetic analyses of synaptic connectivity in epileptic mice with hippocampal grafts of GABAergic interneurons. J. Neurosci. 34, 13492–13504 (2014).
Google Scholar
Tønnesen, J. et al. Functional integration of grafted neural stem cell-derived dopaminergic neurons monitored by optogenetics in an in vitro Parkinson model. PLoS ONE 6, e17560 (2011).
Google Scholar
Weitz, A. J. & Lee, J. H. Probing neural transplant networks in vivo with optogenetics and optogenetic fMRI. Stem Cells Int. 2016, 8612751 (2016).
Google Scholar
Byers, B. et al. Direct in vivo assessment of human stem cell graft–host neural circuits. Neuroimage 114, 328–337 (2015).
Google Scholar
Shao, J. et al. Smartphone-controlled optogenetically engineered cells enable semiautomatic glucose homeostasis in diabetic mice. Sci. Transl. Med. 9, eaal2298 (2017).
Google Scholar
Adil, M. M. et al. Engineered hydrogels increase the post-transplantation survival of encapsulated hESC-derived midbrain dopaminergic neurons. Biomaterials 136, 1–11 (2017).
Google Scholar
Picanço-Castro, V., Moreira, L. F., Kashima, S. & Covas, D. T. Can pluripotent stem cells be used in cell-based therapy? Cell. Reprogram. 16, 98–107 (2014).
Google Scholar
Scholl, H. P. et al. Emerging therapies for inherited retinal degeneration. Sci. Transl. Med. 8, 368rv366 (2016).
Schwartz, S. D. et al. Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt’s macular dystrophy: follow-up of two open-label phase 1/2 studies. Lancet 385, 509–516 (2015).
Google Scholar
Azad, T. D., Veeravagu, A. & Steinberg, G. K. Neurorestoration after stroke. Neurosurg. Focus 40, E2 (2016).
Google Scholar
Wang, W. et al. Tuning the electronic absorption of protein-embedded all-trans-retinal. Science 338, 1340–1343 (2012).
Google Scholar
Gradinaru, V. et al. Molecular and cellular approaches for diversifying and extending optogenetics. Cell 141, 154–165 (2010).
Google Scholar
Zhang, F. et al. Red-shifted optogenetic excitation: a tool for fast neural control derived from Volvox carteri. Nat. Neurosci. 11, 631–633 (2008).
Google Scholar
Yizhar, O. et al. Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature 477, 171–178 (2011).
Google Scholar
Erbguth, K., Prigge, M., Schneider, F., Hegemann, P. & Gottschalk, A. Bimodal activation of different neuron classes with the spectrally red-shifted channelrhodopsin chimera C1V1 in Caenorhabditis elegans. PLoS ONE 7, e46827 (2012).
Google Scholar
Packer, A. M. et al. Two-photon optogenetics of dendritic spines and neural circuits. Nat. Methods 9, 1202–1205 (2012).
Google Scholar
Lin, J. Y., Knutsen, P. M., Muller, A., Kleinfeld, D. & Tsien, R. Y. ReaChR: a red-shifted variant of channelrhodopsin enables deep transcranial optogenetic excitation. Nat. Neurosci. 16, 1499–1508 (2013).
Google Scholar
Inagaki, H. K. et al. Optogenetic control of Drosophila using a red-shifted channelrhodopsin reveals experience-dependent influences on courtship. Nat. Methods 11, 325–332 (2014).
Google Scholar
Klapoetke, N. C. et al. Independent optical excitation of distinct neural populations. Nat. Methods 11, 338–346 (2014).
Google Scholar
Oda, K. et al. Crystal structure of the red light-activated channelrhodopsin Chrimson. Nat. Commun. 9, 3949 (2018).
Google Scholar
Maimon, B. E., Sparks, K., Srinivasan, S., Zorzos, A. N. & Herr, H. M. Spectrally distinct channelrhodopsins for two-colour optogenetic peripheral nerve stimulation. Nat. Biomed. Eng. 2, 485–496 (2018).
Google Scholar
McIsaac, R. S. et al. Directed evolution of a far-red fluorescent rhodopsin. Proc. Natl Acad. Sci. USA 111, 13034–13039 (2014).
Google Scholar
Ma, D. et al. Role of ER export signals in controlling surface potassium channel numbers. Science 291, 316–319 (2001).
Google Scholar
Chuong, A. S. et al. Noninvasive optical inhibition with a red-shifted microbial rhodopsin. Nat. Neurosci. 17, 1123–1129 (2014).
Google Scholar
Müller, K. et al. A red/far-red light-responsive bi-stable toggle switch to control gene expression in mammalian cells. Nucleic Acids Res. 41, e77 (2013).
Google Scholar
Müller, K., Zurbriggen, M. D. & Weber, W. Control of gene expression using a red- and far-red light-responsive bi-stable toggle switch. Nat. Protoc. 9, 622–632 (2014).
Google Scholar
Strauss, H. M., Schmieder, P. & Hughes, J. Light-dependent dimerisation in the N-terminal sensory module of cyanobacterial phytochrome 1. FEBS Lett. 579, 3970–3974 (2005).
Google Scholar
Kim, S., Tathireddy, P., Normann, R. A. & Solzbacher, F. Thermal impact of an active 3-D microelectrode array implanted in the brain. IEEE Trans. Neural Syst. Rehabil. Eng. 15, 493–501 (2007).
Google Scholar
Kienzler, M. A. et al. A red-shifted, fast-relaxing azobenzene photoswitch for visible light control of an ionotropic glutamate receptor. J. Am. Chem. Soc. 135, 17683–17686 (2013).
Google Scholar
Klein, E., Gossler, C., Paul, O. & Ruther, P. High-density μLED-based optical cochlear implant with improved thermomechanical behavior. Front. Neurosci. 12, PMC6174235 (2018).
Park, S. I. et al. Soft, stretchable, fully implantable miniaturized optoelectronic systems for wireless optogenetics. Nat. Biotechnol. 33, 1280–1286 (2015).
Google Scholar
Chow, B. Y. et al. High-performance genetically targetable optical neural silencing by light-driven proton pumps. Nature 463, 98–102 (2010).
Google Scholar
Jeong, J.-W. et al. Wireless optofluidic systems for programmable in vivo pharmacology and optogenetics. Cell 162, 662–674 (2015).
Google Scholar
Folcher, M. et al. Mind-controlled transgene expression by a wireless-powered optogenetic designer cell implant. Nat. Commun. 5, 5392 (2014).
Google Scholar
Noh, K. N. et al. Miniaturized, battery-free optofluidic systems with potential for wireless pharmacology and optogenetics. Small 14, 1702479 (2018).
Park, S. I. et al. Stretchable multichannel antennas in soft wireless optoelectronic implants for optogenetics. Proc. Natl Acad. Sci. USA 113, E8169–E8177 (2016).
Google Scholar
Shin, G. et al. Flexible near-field wireless optoelectronics as subdermal implants for broad applications in optogenetics. Neuron 93, 509–521.e3 (2017).
Google Scholar
Samineni, V. K. et al. Fully implantable, battery-free wireless optoelectronic devices for spinal optogenetics. Pain 158, 2108–2116 (2017).
Google Scholar
Shah, S. et al. Hybrid upconversion nanomaterials for optogenetic neuronal control. Nanoscale 7, 16571–16577 (2015).
Google Scholar
Jayakumar, M. K. G., Idris, N. M. & Zhang, Y. Remote activation of biomolecules in deep tissues using near-infrared-to-UV upconversion nanotransducers. Proc. Natl Acad. Sci. USA 109, 8483–8488 (2012).
Google Scholar
Chen, G., Qiu, H., Prasad, P. N. & Chen, X. Upconversion nanoparticles: design, nanochemistry, and applications in theranostics. Chem. Rev. 114, 5161–5214 (2014).
Google Scholar
Bansal, A., Liu, H., Jayakumar, M. K. G., Andersson-Engels, S. & Zhang, Y. Quasi-continuous wave near-infrared excitation of upconversion nanoparticles for optogenetic manipulation of C. elegans. Small 12, 1732–1743 (2016).
Google Scholar
Idris, N. M. et al. In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers. Nat. Med. 18, 1580–1585 (2012).
Google Scholar
Pliss, A. et al. Subcellular optogenetics enacted by targeted nanotransformers of near-infrared light. ACS Photonics 4, 806–814 (2017).
Google Scholar
Chatterjee, D. K., Gnanasammandhan, M. K. & Zhang, Y. Small upconverting fluorescent nanoparticles for biomedical applications. Small 6, 2781–2795 (2010).
Google Scholar
Toettcher, J. E., Weiner, O. D. & Lim, W. A. Using optogenetics to interrogate the dynamic control of signal transmission by the Ras/Erk module. Cell 155, 1422–1434 (2013).
Google Scholar
Wu, X. et al. Dye-sensitized core/active shell upconversion nanoparticles for optogenetics and bioimaging applications. ACS Nano 10, 1060–1066 (2016).
Google Scholar
Zhao, F. et al. Huge enhancement of upconversion luminescence by dye/Nd 3+ sensitization of quenching-shield sandwich structured upconversion nanocrystals under 808 nm excitation. Dalton Trans. 46, 16180–16189 (2017).
Google Scholar
Chen, S. et al. Near-infrared deep brain stimulation via upconversion nanoparticle-mediated optogenetics. Science 359, 679–684 (2018).
Google Scholar
Zheng, B. et al. Near-infrared light triggered upconversion optogenetic nanosystem for cancer therapy. ACS nano 11, 11898–11907 (2017).
Google Scholar
Han, S., Deng, R., Xie, X. & Liu, X. Enhancing luminescence in lanthanide-doped upconversion nanoparticles. Angew. Chem. Int. Ed. 53, 11702–11715 (2014).
Google Scholar
Lin, X. et al. Multiplexed optogenetic stimulation of neurons with spectrum-selective upconversion nanoparticles. Adv. Healthc. Mater. 6, 1700446 (2017).
Wang, Y. et al. Tetherless near-infrared control of brain activity in behaving animals using fully implantable upconversion microdevices. Biomaterials 142, 136–148 (2017).
Google Scholar
Kwon, K. Y., Lee, H.-M., Ghovanloo, M., Weber, A. & Li, W. Design, fabrication, and packaging of an integrated, wirelessly-powered optrode array for optogenetics application. Front. Syst. Neurosci. 9, 69 (2015).
Google Scholar
Gerits, A. & Vanduffel, W. Optogenetics in primates: a shining future? Trends Genet. 29, 403–411 (2013).
Google Scholar
Chernov, M. M., Friedman, R. M., Chen, G., Stoner, G. R. & Roe, A. W. Functionally specific optogenetic modulation in primate visual cortex. Proc. Natl Acad. Sci. USA 115, 10505–10510 (2018).
Google Scholar
Koch, S. F. et al. Halting progressive neurodegeneration in advanced retinitis pigmentosa. J. Clin. Invest. 125, 3704–3713 (2015).
Google Scholar
Keppeler, D. et al. Ultrafast optogenetic stimulation of the auditory pathway by targeting-optimized Chronos. EMBO J. 37, e99649 (2018).
Google Scholar
Schenkl, S., van Mourik, F., van der Zwan, G., Haacke, S. & Chergui, M. Probing the ultrafast charge translocation of photoexcited retinal in bacteriorhodopsin. Science 309, 917–920 (2005).
Google Scholar
Groth, G. & Walker, J. E. ATP synthase from bovine heart mitochondria: reconstitution into unilamellar phospholipid vesicles of the pure enzyme in a functional state. Biochem. J. 318, 351–357 (1996).
Google Scholar
Li, D., Hérault, K., Isacoff, E. Y., Oheim, M. & Ropert, N. Optogenetic activation of LiGluR-expressing astrocytes evokes anion channel-mediated glutamate release. J. Physiol. 590, 855–873 (2012).
Google Scholar
Levskaya, A., Weiner, O. D., Lim, W. A. & Voigt, C. A. Spatiotemporal control of cell signalling using a light-switchable protein interaction. Nature 461, 997–1001 (2009).
Google Scholar
Shimizu-Sato, S., Huq, E., Tepperman, J. M. & Quail, P. H. A light-switchable gene promoter system. Nat. Biotechnol. 20, 1041–1044 (2002).
Google Scholar
Mühlhäuser, W. W., Hörner, M., Weber, W. & Radziwill, G. in Synthetic Protein Switches 257–270 (Springer, 2017).
Zhang, K. et al. Light-mediated kinetic control reveals the temporal effect of the Raf/MEK/ERK pathway in PC12 cell neurite outgrowth. PLoS ONE 9, e92917 (2014).
Google Scholar
Kim, N. et al. Spatiotemporal control of fibroblast growth factor receptor signals by blue light. Chem. Biol. 21, 903–912 (2014).
Google Scholar
Wend, S. et al. Optogenetic control of protein kinase activity in mammalian cells. ACS Synth. Biol. 3, 280–285 (2013).
Google Scholar
Zhou, X. X., Fan, L. Z., Li, P., Shen, K. & Lin, M. Z. Optical control of cell signaling by single-chain photoswitchable kinases. Science 355, 836–842 (2017).
Google Scholar
Strickland, D. et al. TULIPs: tunable, light-controlled interacting protein tags for cell biology. Nat. Methods 9, 379–384 (2012).
Google Scholar
Renicke, C., Schuster, D., Usherenko, S., Essen, L.-O. & Taxis, C. A LOV2 domain-based optogenetic tool to control protein degradation and cellular function. Chem. Biol. 20, 619–626 (2013).
Google Scholar
Bonger, K. M., Rakhit, R., Payumo, A. Y., Chen, J. K. & Wandless, T. J. General method for regulating protein stability with light. ACS Chem. Biol. 9, 111–115 (2013).
Google Scholar
Crefcoeur, R. P., Yin, R., Ulm, R. & Halazonetis, T. D. Ultraviolet-B-mediated induction of protein–protein interactions in mammalian cells. Nat. Commun. 4, 1779 (2013).
Google Scholar
Müller, K., Engesser, R., Timmer, J., Zurbriggen, M. D. & Weber, W. Orthogonal optogenetic triple-gene control in mammalian cells. ACS Synth. Biol. 3, 796–801 (2014).
Google Scholar
Sukhotinsky, I. et al. Optogenetic delay of status epilepticus onset in an in vivo rodent epilepsy model. PLoS ONE 8, e62013 (2013).
Google Scholar
Paz, J. T. et al. Closed-loop optogenetic control of thalamus as a tool for interrupting seizures after cortical injury. Nat. Neurosci. 16, 64–70 (2013).
Google Scholar
Gu, L. et al. Pain inhibition by optogenetic activation of specific anterior cingulate cortical neurons. PLoS ONE 10, e0117746 (2015).
Google Scholar
Gradinaru, V., Mogri, M., Thompson, K. R., Henderson, J. M. & Deisseroth, K. Optical deconstruction of parkinsonian neural circuitry. Science 324, 354–359 (2009).
Google Scholar
Bryson, J. B. et al. Optical control of muscle function by transplantation of stem cell–derived motor neurons in mice. Science 344, 94–97 (2014).
Google Scholar
Tennant, K. A., Taylor, S. L., White, E. R. & Brown, C. E. Optogenetic rewiring of thalamocortical circuits to restore function in the stroke injured brain. Nat. Commun. 8, 15879 (2017).
Google Scholar
Cheng, M. Y. et al. Optogenetic neuronal stimulation promotes functional recovery after stroke. Proc. Natl Acad. Sci. USA 111, 12913–12918 (2014).
Google Scholar
Alex, A., Li, A., Tanzi, R. E. & Zhou, C. Optogenetic pacing in Drosophila melanogaster. Sci. Adv. 1, e1500639 (2015).
Google Scholar
Bruegmann, T. et al. Optogenetic control of contractile function in skeletal muscle. Nat. Commun. 6, 7153 (2015).
Google Scholar
Mei, Y. & Zhang, F. Molecular tools and approaches for optogenetics. Biol. Psychiatry 71, 1033–1038 (2012).
Google Scholar
Venkatachalam, V. & Cohen, A. E. Imaging GFP-based reporters in neurons with multiwavelength optogenetic control. Biophys. J. 107, 1554–1563 (2014).
Google Scholar
